|
🦁
|
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties
8 auth.
T. Chiba,
Kaoru Kita,
Yun-Wen Zheng,
O. Yokosuka,
H. Saisho,
A. Iwama,
...
H. Nakauchi,
H. Taniguchi
|
9 |
2006 |
9
🦁
|
|
🦁
|
The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
11 auth.
T. Chiba,
S. Miyagi,
A. Saraya,
Ryutaro Aoki,
Atsuyoshi Seki,
Yohei Morita,
...
Yutaka Yonemitsu,
O. Yokosuka,
H. Taniguchi,
H. Nakauchi,
A. Iwama
|
7 |
2008 |
7
🦁
|
|
🦁
|
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.
13 auth.
T. Chiba,
Yun-Wen Zheng,
Kaoru Kita,
O. Yokosuka,
H. Saisho,
M. Onodera,
H. Miyoshi,
M. Nakano,
Y. Zen,
Y. Nakanuma,
...
H. Nakauchi,
A. Iwama,
H. Taniguchi
|
7 |
2007 |
7
🦁
|
|
🐜
|
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.
12 auth.
Satomi Tanaka,
S. Miyagi,
G. Sashida,
T. Chiba,
Jin Yuan,
Makiko Mochizuki-Kashio,
...
Yutaka Suzuki,
S. Sugano,
C. Nakaseko,
K. Yokote,
H. Koseki,
A. Iwama
|
7 |
2012 |
7
🐜
|
|
🐜
|
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
22 auth.
R. Tateishi,
Koji Uchino,
N. Fujiwara,
T. Takehara,
T. Okanoue,
M. Seike,
H. Yoshiji,
H. Yatsuhashi,
M. Shimizu,
T. Torimura,
...
M. Moriyama,
I. Sakaida,
H. Okada,
T. Chiba,
M. Chuma,
K. Nakao,
H. Isomoto,
Y. Sasaki,
S. Kaneko,
T. Masaki,
K. Chayama,
K. Koike
|
7 |
2018 |
7
🐜
|
|
🐜
|
The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.
14 auth.
Yuta Mishima,
S. Miyagi,
A. Saraya,
M. Negishi,
Mitsuhiro Endoh,
T. Endo,
Tetsuro Toyoda,
J. Shinga,
T. Katsumoto,
T. Chiba,
...
N. Yamaguchi,
I. Kitabayashi,
H. Koseki,
A. Iwama
|
7 |
2011 |
7
🐜
|
|
🐜
|
Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
10 auth.
S. Ogasawara,
T. Chiba,
Y. Ooka,
Naoya Kanogawa,
T. Motoyama,
E. Suzuki,
...
A. Tawada,
F. Kanai,
M. Yoshikawa,
O. Yokosuka
|
7 |
2014 |
7
🐜
|
|
🦁
|
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells.
9 auth.
T. Chiba,
O. Yokosuka,
M. Arai,
Motohisa Tada,
K. Fukai,
F. Imazeki,
...
Masaki Kato,
N. Seki,
H. Saisho
|
6 |
2004 |
6
🦁
|
|
🦁
|
3‐Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor‐initiating hepatocellular carcinoma cells
12 auth.
T. Chiba,
E. Suzuki,
M. Negishi,
A. Saraya,
S. Miyagi,
T. Konuma,
...
Satomi Tanaka,
Motohisa Tada,
F. Kanai,
F. Imazeki,
A. Iwama,
O. Yokosuka
|
6 |
2012 |
6
🦁
|
|
🦁
|
Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma Cells
8 auth.
T. Chiba,
O. Yokosuka,
K. Fukai,
H. Kojima,
Motohisa Tada,
M. Arai,
...
F. Imazeki,
H. Saisho
|
6 |
2004 |
6
🦁
|
|
🦁
|
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
15 auth.
T. Chiba,
Tomoko Saito,
Kaori Yuki,
Y. Zen,
S. Koide,
Naoya Kanogawa,
T. Motoyama,
S. Ogasawara,
E. Suzuki,
Y. Ooka,
...
A. Tawada,
M. Otsuka,
M. Miyazaki,
A. Iwama,
O. Yokosuka
|
6 |
2015 |
6
🦁
|
